A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

Overview of attention for article published in Blood, May 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Dimensions has found 486 publications that cite this research output.

Article in Cancer Reports (April 2024)

Article in npj Precision Oncology (March 2024)

Article in Sudan Journal of Medical Sciences (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.